Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nincy Debeuf

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Allergy and Clinical Immunology|September 10, 2021
The STE20 kinase TAOK3 controls the development of house dust mite-induced asthma in miceBastiaan Maes, Ursula Smole, Matthias Vanderkerken, et al.
Science Immunology|November 28, 2025
Maternal allergy and neonatal RSV infection synergize via FcR-mediated allergen uptake to promote the development of asthma in early lifeElisabeth De Leeuw, Josefine F Justesen, Cédric Bosteels, et al.
Immunity|May 12, 2020
Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus InfectionCedric Bosteels, Katrijn Neyt, Manon Vanheerswynghels, et al.
Cell Reports|November 27, 2025
GM-CSF and specific type 2 cytokines induce CD103<sup>+</sup> and CD301b<sup>+</sup> cell states in cDC1s and cDC2sLukas Amon, Damir Vurnek, Anna Seichter, et al.
Science Translational Medicine|August 23, 2023
A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19Karel F A Van Damme, Levi Hoste, Jozefien Declercq, et al.
Respiratory Research|August 9, 2022
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trialElisabeth De Leeuw, Karel F A Van Damme, Jozefien Declercq, et al.
Cell Reports. Medicine|December 2, 2022
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatmentCedric Bosteels, Karel F A Van Damme, Elisabeth De Leeuw, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Allergy and Clinical Immunology|September 10, 2021
The STE20 kinase TAOK3 controls the development of house dust mite-induced asthma in miceBastiaan Maes, Ursula Smole, Matthias Vanderkerken, et al.
Science Immunology|November 28, 2025
Maternal allergy and neonatal RSV infection synergize via FcR-mediated allergen uptake to promote the development of asthma in early lifeElisabeth De Leeuw, Josefine F Justesen, Cédric Bosteels, et al.
Immunity|May 12, 2020
Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus InfectionCedric Bosteels, Katrijn Neyt, Manon Vanheerswynghels, et al.
Cell Reports|November 27, 2025
GM-CSF and specific type 2 cytokines induce CD103<sup>+</sup> and CD301b<sup>+</sup> cell states in cDC1s and cDC2sLukas Amon, Damir Vurnek, Anna Seichter, et al.
Science Translational Medicine|August 23, 2023
A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19Karel F A Van Damme, Levi Hoste, Jozefien Declercq, et al.
Respiratory Research|August 9, 2022
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trialElisabeth De Leeuw, Karel F A Van Damme, Jozefien Declercq, et al.
Cell Reports. Medicine|December 2, 2022
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatmentCedric Bosteels, Karel F A Van Damme, Elisabeth De Leeuw, et al.
Pageof 2